QR Kod

Use of Mepolizumab in Children and Adolescents with Asthma in the USA

Introduction: Pediatric asthma affects 5.5 million US children and is the leading cause of pediatric chronic illness globally. Those with severe asthma have significantly higher healthcare costs compared to those with non-severe disease. Biologics are the newest class of anti-asthma therapy approved...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Jaclyn Davis, Pamela M. McMahon, Emily Welch, Cheryl McMahill-Walraven, Aziza Jamal-Allial, Tancy Zhang, Christine Draper, Anne Marie Kline, Leslie Koerner, Jeffrey S. Brown, Melissa Van Dyke, Ann Chen Wu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI AG 2022-07-01
Seri Bilgileri:Journal of Respiration
Konular:
asthma
pediatric
mepolizumab
biologics
Online Erişim:https://www.mdpi.com/2673-527X/2/3/10
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller